Tonix Pharmaceuticals Holding Corp. Contract with Customer, Asset, after Allowance for Credit Loss, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2026-08-10
- 2026-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $3.25M.
- 2026-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $3.39M.
- 2025-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $3.48M.
- 2025-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.67M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $3.25M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $3.39M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $3.48M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.90M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.29M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $881.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $4.59M 10-K · filed 2025-03-18 |
| 2022-12-31 | $8.04M 10-K · filed 2024-04-01 |